Deleted Tweets From Scott Gottlieb, R-D.C.

March 19 #FDA workshop on Patient-Focused Drug Development: Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data #PFDD https://t.co/ds5GQMBVEL

In 2017 #FDA approved a record number of novel devices at 95; a record number of generic drugs at 1,027; and a record number of novel drugs and biologics. This progress is a product of efforts of #FDA professional staff; set against a moment of accelerati

#FDA approved a record number of generic drugs in 2017 -- 1,027 total approvals. In addition to building on these gains in 2018; FDA will also advance policies to promote more development, competition, adoption of biosimilars https://t.co/Zh0kPG3Mv4

RT @FDAOncology: Sean Khozin of @FDAOncology on computer modeling for #clinicaltrials https://t.co/vo8Cw4sEw6 (paywall)

#FDA’s record number of novel 2017 approvals of drugs and biologics (56); devices (95); and generics (1,027) was culmination of years of dedicated efforts by staff to modernize policies; a wave of scientific progress; and new legislation like Cures Act th

RT @FDA_Drug_Info: #FDA Public Workshop on “New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inha… https://t.co/tBdNjkkFYF

RT @califf001: Can digital nudges help bring this under control? https://t.co/O690Fv81Qt QT @wef: The world’s biggest killers? Diseases linked to human behaviour https://t.co/2R9Tb4sFiH https://t.co/hcGmVzwK7D)

RT @mcipriano93: .@US FDA Sets Records With Breakthrough Therapy, Priority Review Designations In 2017 https://t.co/hnOXX7UAOA

RT @FDAOncology: #FDA public listening session March 15, request for comments about the Oncology Center of Excellence. Registration:… https://t.co/33JgX67GLb

RT @Surgeon_General: Honored to be chosen as Power Player of the Week on @FoxNewsSunday. Enjoyed speaking with Chris Wallace about our c… https://t.co/ZmLTIlDcv4

To build on our record-setting 1,027 generic approvals in 2017; among other new steps, in 2018 #FDA will advance policies aimed at reducing the multiple times the same application will undergo a review cycle before it's approved https://t.co/mekgXv9Rhe ht

RT @CDCFlu: Latest #FluView shows the number of states reporting widespread #flu activity increased from 36 to 46 this week.… https://t.co/oZgMIs2ji0

RT @FDAOncology: Harnessing the Power of Collaboration - interview with @FDAOncology Richard Pazdur via @ASHClinicalNews https://t.co/AIG21msMkf

RT @FDA_Drug_Info: An important GDUFA Regulatory Science priority is to develop predictive models of complex inhaled drug delivery. https://t.co/hnHheg3Qom

RT @SeanKhozin: “Nobody innovates in a silo. Advancements [...] r possible only because of the collaboration of the public health community… QT @SGottliebFDA: My New Blog: Landmark year of progress at #FDA - record medical product approvals, new efforts to protect public vi… https://t.co/8UXwwoPfXq)

My statement on FDA and state of life science innovation: In addition to a modern record number of novel drugs approved in 2017; #FDA also set two all-time records with 56 breakthrough designations and 82 priority reviews granted on pipeline drugs https:/

RT @US_FDA: Reminder: Jan. 11 FDA Grand Rounds unveils breakthrough FDA research on ethnic and gender differences in Alzheimer’… https://t.co/ipkepOSxLV

Read #FDA’s new report “Advancing Health through Innovation: New Drug Approvals and Other Drug Therapy Advances of 2017” to learn about important drug therapy approvals that occurred last year. https://t.co/sPApD0UEZU https://t.co/VerGbFCN1r

RT @DrMayneFDAFood: Do you have food allergies? Get recalls & allergy alerts automatically by email so you can avoid problem foods… https://t.co/88HyWV2eZT

RT @EllenJMacKenzie: On Tuesday (1/16), we're convening experts to discuss the importance of open data and transparency at the @US_FDA.… https://t.co/GavLH9EvKN

March 19 #FDA workshop on Patient-Focused Drug Development: Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data #PFDD https://t.co/ds5GQMBVEL

In 2017 #FDA approved a record number of novel devices at 95; a record number of generic drugs at 1,027; and a record number of novel drugs and biologics. This progress is a product of efforts of #FDA professional staff; set against a moment of accelerati

#FDA approved a record number of generic drugs in 2017 -- 1,027 total approvals. In addition to building on these gains in 2018; FDA will also advance policies to promote more development, competition, adoption of biosimilars https://t.co/Zh0kPG3Mv4

RT @FDAOncology: Sean Khozin of @FDAOncology on computer modeling for #clinicaltrials https://t.co/vo8Cw4sEw6 (paywall)

#FDA’s record number of novel 2017 approvals of drugs and biologics (56); devices (95); and generics (1,027) was culmination of years of dedicated efforts by staff to modernize policies; a wave of scientific progress; and new legislation like Cures Act th

RT @FDA_Drug_Info: #FDA Public Workshop on “New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inha… https://t.co/tBdNjkkFYF

RT @califf001: Can digital nudges help bring this under control? https://t.co/O690Fv81Qt QT @wef: The world’s biggest killers? Diseases linked to human behaviour https://t.co/2R9Tb4sFiH https://t.co/hcGmVzwK7D)

RT @mcipriano93: .@US FDA Sets Records With Breakthrough Therapy, Priority Review Designations In 2017 https://t.co/hnOXX7UAOA

RT @FDAOncology: #FDA public listening session March 15, request for comments about the Oncology Center of Excellence. Registration:… https://t.co/33JgX67GLb

RT @Surgeon_General: Honored to be chosen as Power Player of the Week on @FoxNewsSunday. Enjoyed speaking with Chris Wallace about our c… https://t.co/ZmLTIlDcv4

To build on our record-setting 1,027 generic approvals in 2017; among other new steps, in 2018 #FDA will advance policies aimed at reducing the multiple times the same application will undergo a review cycle before it's approved https://t.co/mekgXv9Rhe ht

RT @CDCFlu: Latest #FluView shows the number of states reporting widespread #flu activity increased from 36 to 46 this week.… https://t.co/oZgMIs2ji0

RT @FDAOncology: Harnessing the Power of Collaboration - interview with @FDAOncology Richard Pazdur via @ASHClinicalNews https://t.co/AIG21msMkf

RT @FDA_Drug_Info: An important GDUFA Regulatory Science priority is to develop predictive models of complex inhaled drug delivery. https://t.co/hnHheg3Qom

RT @SeanKhozin: “Nobody innovates in a silo. Advancements [...] r possible only because of the collaboration of the public health community… QT @SGottliebFDA: My New Blog: Landmark year of progress at #FDA - record medical product approvals, new efforts to protect public vi… https://t.co/8UXwwoPfXq)

My statement on FDA and state of life science innovation: In addition to a modern record number of novel drugs approved in 2017; #FDA also set two all-time records with 56 breakthrough designations and 82 priority reviews granted on pipeline drugs https:/

RT @US_FDA: Reminder: Jan. 11 FDA Grand Rounds unveils breakthrough FDA research on ethnic and gender differences in Alzheimer’… https://t.co/ipkepOSxLV

Read #FDA’s new report “Advancing Health through Innovation: New Drug Approvals and Other Drug Therapy Advances of 2017” to learn about important drug therapy approvals that occurred last year. https://t.co/sPApD0UEZU https://t.co/VerGbFCN1r

RT @DrMayneFDAFood: Do you have food allergies? Get recalls & allergy alerts automatically by email so you can avoid problem foods… https://t.co/88HyWV2eZT

RT @EllenJMacKenzie: On Tuesday (1/16), we're convening experts to discuss the importance of open data and transparency at the @US_FDA.… https://t.co/GavLH9EvKN